Omnia Molecular
Designs and develops anti-infectives targeted at difficult-to-treat infections.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
€640k | Grant | ||
Total Funding | AUD1.1m |
Recent News about Omnia Molecular
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.